deferasirox synthon 180mg film-coated tablets
synthon bv microweg 22, 6545 cm nijmegen, netherlands - deferasirox - film-coated tablet - deferasirox 180 mg - all other therapeutic products
deferasirox synthon 90mg film-coated tablets
synthon bv microweg 22, 6545 cm nijmegen, netherlands - deferasirox - film-coated tablet - deferasirox 90 mg - all other therapeutic products
deferasirox synthon 360mg film-coated tablets
synthon bv microweg 22, 6545 cm nijmegen, netherlands - deferasirox - film-coated tablet - deferasirox 360 mg - all other therapeutic products
deferasirox synthon hispania 90mg film-coated tablets
synthon hispania, s.l. calle castello 1, 08830 sant boi de llobregat, barcelona, spain - deferasirox - film-coated tablet - deferasirox 90 mg - all other therapeutic products
deferasirox synthon hispania 360mg film-coated tablets
synthon hispania, s.l. calle castello 1, 08830 sant boi de llobregat, barcelona, spain - deferasirox - film-coated tablet - deferasirox 360 mg - all other therapeutic products
deferasirox synthon hispania 180mg film-coated tablets
synthon hispania, s.l. calle castello 1, 08830 sant boi de llobregat, barcelona, spain - deferasirox - film-coated tablet - deferasirox 180 mg - all other therapeutic products
deferasirox bioorganics 180mg film-coated tablets
bioorganics bv microweg 22, 6545cm nijmegen, netherlands - deferasirox - film-coated tablet - deferasirox 180 mg - all other therapeutic products
deferasirox bioorganics 90mg film-coated tablets
bioorganics bv microweg 22, 6545cm nijmegen, netherlands - deferasirox - film-coated tablet - deferasirox 90 mg - all other therapeutic products
deferasirox bioorganics 360mg film-coated tablets
bioorganics bv microweg 22, 6545cm nijmegen, netherlands - deferasirox - film-coated tablet - deferasirox 360 mg - all other therapeutic products
deferasirox teva 125 mg
teva israel ltd - deferasirox - tablets dispersible - deferasirox 125 mg - deferasirox - deferasirox teva is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in adult and pediatric patients (aged 2 years and over). deferasirox teva is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 μg /l).lic is the preferred method of iron overload determination and should be used wherever available.